Difference between revisions of "Osocimab (BAY-1213790)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== Anti-Factor XIa antibody ==Preliminary data== ===Venous thromboembolism=== # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freita...") |
Warner-admin (talk | contribs) m (Text replacement - "http://www.ncbi.nlm.nih.gov/pmc" to "https://www.ncbi.nlm.nih.gov/pmc") |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Preliminary data== | ==Preliminary data== | ||
===[[Venous thromboembolism]]=== | ===[[Venous thromboembolism]]=== | ||
| − | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https:// | + | # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. [https://doi.org/10.1001/jama.2019.20687 link to original article] [https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6990695/ link to PMC article] [https://pubmed.ncbi.nlm.nih.gov/31935028/ PubMed] |
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' BAY-1213790 | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Latest revision as of 12:18, 23 June 2024
Mechanism of action
Anti-Factor XIa antibody
Preliminary data
Venous thromboembolism
- FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article link to PMC article PubMed
Also known as
- Code name: BAY-1213790